Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Drugs Process-for-preparing-anti-obesity-protein

 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
The present invention overcomes the above mentioned drawbacks and provides methods for treating ...


 Antibody against a 3-aminophenylboronic-glycated protein complex and its use in an immunoassay
OF THE INVENTION The present invention is directed to methods for developing and utilizing ...


 Application of phytosterols (and their isomers), folic acid, cyanocobalamin and pyridoxin in dietetic (alimentary) fibers
The invention claimed is: 1. An oral pharmaceutical formulation comprising phytosterols and isomers ...


 Stimulation of chemotaxis by chemotactic peptides
Accordingly, it is an object of this invention to provide a synthetic material having chemotactic ...


 Biological material pre-fixation treatment
OF PREFERRED EMBODIMENTS In one aspect, the present invention relates to an improved bioprosthetic ...


 Diagnosis of Williams syndrome
OF THE INVENTION The present invention is directed to the determination that SVAS and Williams ...


 Biological material pre-fixation treatment
OF PREFERRED EMBODIMENTS In one aspect, the present invention relates to an improved bioprosthetic ...


 Method for bonding or fusion of biological tissue and material
Biological materials are joined, repaired or fused by heating the material in proximity to a ...


 Diagnosis and treatment of supravalvular aortic stenosis and Williams syndrome
OF THE INVENTION The present invention is directed to the determination that SVAS and Williams ...


 Biological material pre-fixation treatment
OF PREFERRED EMBODIMENTS In one aspect, the present invention relates to an improved bioprosthetic ...


 Process for preparing anti-obesity protein

Details
Inventors: MacKellar, Warren C.;
Assignee: Eli Lilly and Company (Indianapolis, IN)
Primary Examiner: Lilling; Herbert J.
Assistant Examiner:
Attorney, Agent or Firm: Caltrider; Steven P., Boone; David E.

The present invention is directed to a novel process of preparing an anti-obesity protein using dipeptidyl-aminopeptidase isolated from the cellular slime mold, Dictyostelium discodeum. The process produces an anti-obesity protein in high yield.

DETAILED DESCRIPTION OF THE INVENTION For purposes of the present invention, as disclosed and claimed herein, the following terms and abbreviations are as defined below.
dDAP--a dipeptidylaminopeptidase, isolated from Dictyostelium discoideum, which demonstrates a pH optimum of about pH 3.
5 with GFpNA as a substrate and has a native molecular weight of about 225,000 daltons, as measured by analytical ultracentrifugation, and a subunit molecular weight of about 66,000 daltons, as measured by SDS polyacrylamide gel electrophoresis.
Support surface--any solid or semi-solid surface or matrix that can be used as is or easily derivatized or activated to bond a protein, exhibits minimal non-specific adsorption, is physically mechanically and chemically stable, is highly porous to provide ligand accessibility, and can be regenerated without deteriorating the surface.
dDAP bed--any amount of dDAP immobilized to a single or multiple support surface that forms an aggregate volume or unit of immobilized dDAP.
GFpNA--Gly-Phe p-nitroanilide.
SEQ ID NO: 1 refers to the sequence set forth in the sequence listing and means an anti-obesity protein of the formula: ##STR1## wherein: Xaa at position 4 is Gln or Glu; Xaa at position 7 is Gln or Glu; Xaa at position 22 is Gln, Asn, or Asp; Xaa at position 27 is Thr or Ala; Xaa at position 28 is Gln, Glu, or absent; Xaa at position 34 is Gln or Glu; Xaa at position 54 is Met, methionine sulfoxide, Leu, Ile, Val, Ala, or Gly; Xaa at position 56 is Gln or Glu; Xaa at position 62 is Gln or Glu; Xaa at position 63 is Gln or Glu; Xaa at position 68 is Met, methionine sulfoxide, Leu, Ile, Val, Ala, or Gly; Xaa at position 72 is Gln, Asn, or Asp; Xaa at position 75 is Gln or Glu; Xaa at position 78 is Gln, Asn, or Asp; Xaa at position 82 is Gln, Asn, or Asp; Xaa at position 100 is Gln, Trp, Tyr, Phe, Ile, Val, or Leu; Xaa at position 108 is Asp or Glu; Xaa at position 130 is Gln or Glu; Xaa at position 134 is Gln or Glu; Xaa at position 136 is Met, methionine sulfoxide, Leu, Ile, Val, Ala, or Gly; Xaa at position 138 is Gln, Trp, Tyr, Phe, Ile, Val, or Leu; and Xaa at position 139 is Gln or Glu



Related patents
  Use of GLP-1 or analogs to abolish catabolic changes after surgery
The present invention therefore presents for the first time a method of attenuating post-surgical catabolic changes and insulin resistance, comprising, administering to ...
  Effects of sporoderm-broken germination activated ganoderma spores on treatment of spinal cord injury
OF THE INVENTION The present invention provides a method for effective treatment of spinal cord injury. The method involves administering an effective amount of ...
  Leptospira rare outer membrane proteins
The present invention presents two novel leptospiral membrane proteins: LipL1 and LipL2. In particular, these proteins are lipoproteins which are associated with ...
  Interleukin-1 beta converting enzyme like apoptotic protease-6
Toward these ends, and others, it is an object of the present invention to provide polypeptides, inter alia, that have been identified as novel ICE LAP-6 by homology ...
  Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies
What is claimed is: 1. A therapeutic composition comprising at least one angiogenesis inhibiting agent, which is an .alpha..sub.v.beta..sub.3 antagonist; and at least ...
  Expressed sequence tags and encoded human proteins
The present invention relates to purified, isolated, or enriched 5' ESTs which include sequences derived from the authentic 5' ends of their corresponding mRNAs. The ...
  C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof
The invention claimed is: 1. An isolated PC-LECTIN protein comprising the amino acid sequence of SEQ ID NO. 2. 2. The PC-LECTIN protein of claim 1 which is soluble. 3. ...
  Antibodies for use in determining hemoglobin A.sub.1c
It is accordingly an object of the present invention to provide a comparatively simple, inexpensive, reliable test for determining the long-term blood sugar level of a ...
  Haptens, tracers, immunogens and antibodies for immunoassays for cotinine derivatives
OF THE INVENTION A hapten of the invention is substantially optically pure, and is particularly useful in an immunoassay for cotinine, a metabolite of nicotine. As used ...
  Immunogens and the use thereof for obtaining antibodies against HBA.sub.1C
What is claimed is: 1. Composition of matter consisting essentially of polyclonal antibodies which specifically bind to HbA.sub.1c and which have less than 5.0% cross ...

0.064

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved